Clinical Trial Update: Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients [NA]

View source ↗

Summary

This clinical trial update reports on a four-drug combination therapy (Zidovudine, Lamivudine, Abacavir, and Amprenavir) for HIV infection, with the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Agenerase (Amprenavir) (Amprenavir)
• Epivir (lamivudine) (lamivudine)
• Retrovir (zidovudine) (zidovudine)
• Ziagen (abacavir) (abacavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED